|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-1-27
|
|
pubmed:abstractText |
Primary chemotherapy was administered to patients with tumors that measured > or = 2.5 cm in largest diameter to decrease the size of the primary tumor and allow for effective local and distant control while avoiding mastectomy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
93-100
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9440728-Adult,
pubmed-meshheading:9440728-Aged,
pubmed-meshheading:9440728-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9440728-Breast Neoplasms,
pubmed-meshheading:9440728-Cisplatin,
pubmed-meshheading:9440728-Combined Modality Therapy,
pubmed-meshheading:9440728-Disease Progression,
pubmed-meshheading:9440728-Female,
pubmed-meshheading:9440728-Fluorouracil,
pubmed-meshheading:9440728-Follow-Up Studies,
pubmed-meshheading:9440728-Humans,
pubmed-meshheading:9440728-Methotrexate,
pubmed-meshheading:9440728-Middle Aged,
pubmed-meshheading:9440728-Prospective Studies,
pubmed-meshheading:9440728-Survival Analysis,
pubmed-meshheading:9440728-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
|
|
pubmed:affiliation |
Department of Medicine, Istituto Nazionale Tumori, Milan, Italy. bonadonna@istitutotumori.mi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
